Cargando…
The identification of metabolites from gut microbiota in NAFLD via network pharmacology
The metabolites of gut microbiota show favorable therapeutic effects on nonalcoholic fatty liver disease (NAFLD), but the active metabolites and mechanisms against NAFLD have not been documented. The aim of the study was to investigate the active metabolites and mechanisms of gut microbiota against...
Autores principales: | Oh, Ki-Kwang, Gupta, Haripriya, Min, Byeong Hyun, Ganesan, Raja, Sharma, Satya Priya, Won, Sung Min, Jeong, Jin Ju, Lee, Su Been, Cha, Min Gi, Kwon, Goo Hyun, Jeong, Min Kyo, Hyun, Ji Ye, Eom, Jung A, Park, Hee Jin, Yoon, Sang Jun, Choi, Mi Ran, Kim, Dong Joon, Suk, Ki Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839744/ https://www.ncbi.nlm.nih.gov/pubmed/36639568 http://dx.doi.org/10.1038/s41598-023-27885-w |
Ejemplares similares
-
Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
por: Oh, Ki-Kwang, et al.
Publicado: (2022) -
Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study
por: Oh, Ki-Kwang, et al.
Publicado: (2022) -
The Link between Gut Microbiota and Hepatic Encephalopathy
por: Won, Sung-Min, et al.
Publicado: (2022) -
Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022) -
The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
por: Oh, Ki-Kwang, et al.
Publicado: (2023)